The Role of Biomarkers and Surrogate End Points in Drug Development for Neonatal Pulmonary Arterial Hypertension

Por Sun, Haihao, Stockbridge, Norman, Ariagno, Ronald L., Murphy, Dianne
Publicado no Neoreviews (2016)

Bioluminescent imaging study: FAK inhibitor, PF-562,271, preclinical study in PC3M-luc-C6 local implant and metastasis xenograft models

Por Sun, Haihao, Pisle, Stephen, Gardner, Erin R, Figg, William D
Publicado em 2010

Extrapolation of Efficacy in Pediatric Drug Development and Evidence-based Medicine: Progress and Lessons Learned

Por Sun, Haihao, Temeck, Jean W., Chambers, Wiley, Perkins, Ginger, Bonnel, Renan, Murphy, Dianne
Publicado no Ther Innov Regul Sci (2017)

Phase II Trial of Bevacizumab, Thalidomide, Docetaxel, and Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer

Por Ning, Yang-Min, Gulley, James L., Arlen, Philip M., Woo, Sukyung, Steinberg, Seth M., Wright, John J., Parnes, Howard L., Trepel, Jane B., Lee, Min-Jung, Kim, Yeong Sang, Sun, Haihao, Madan, Ravi A., Latham, Lea, Jones, Elizabeth, Chen, Clara C., Figg, William D., Dahut, William L.
Publicado em 2010